Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00399230 · ClinicalTrials.gov registry record · Phase 4
A Comparison of Optive in Patients Previously Using Systane for the Treatment of Dry Eye
A Phase 4 study, sponsored by Innovative Medical.
- Completed
- Registry status
- Phase 4
- Development phase
NCT00399230: Completed Phase 4 study, sponsored by Innovative Medical.
NCT00399230 is a Phase 4 study that has completed, run by Innovative Medical. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00399230, a Phase 4 study, has completed, sponsored by Innovative Medical.
- COMPLETED
- Registry status
- Phase 4
- Development phase
Study Summary
To evaluate the effectiveness of NGT (Optive) vs. Systane Tears for patients with moderate to severe dry eye disease.
Interventions
- DRUG Optive
Trial Details
| Field | Value |
|---|---|
| Phase | Phase 4 |
What the finished NCT00399230 record still lists
NCT00399230 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Optive is the first listed.
NCT00399230 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00399230 about?
NCT00399230 is a clinical study titled "A Comparison of Optive in Patients Previously Using Systane for the Treatment of Dry Eye". To evaluate the effectiveness of NGT (Optive) vs. Systane Tears for patients with moderate to severe dry eye disease.
What is the current status of trial NCT00399230?
This trial is currently completed. It is a Phase 4 study.
What interventions are being tested in trial NCT00399230?
The interventions under investigation include: Optive (DRUG).
Who is sponsoring clinical trial NCT00399230?
This trial is sponsored by Innovative Medical, which has 44 total clinical trials registered on ClinicalTrials.gov.